Implementation of a Pharmacist in an Adult Transplant Outpatient Clinic (Kidney, Liver, Pancreas): A Pilot Study – Implant
1Pharmacy, McGill University Health Centre, Montréal, QC, Canada, 2Division of Nephrology, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada
Meeting: 2020 American Transplant Congress
Abstract number: B-214
Keywords: Adverse effects, Immunosuppression, Outpatients, Patient education
Session Information
Session Name: Poster Session B: Quality Assurance Process Improvement & Regulatory Issues
Session Type: Poster Session
Date: Saturday, May 30, 2020
Session Time: 3:15pm-4:00pm
Presentation Time: 3:30pm-4:00pm
Location: Virtual
*Purpose: Solid organ transplant (SOT) patients require a complex medication regimen which increases the risk of many drug-related problems. The purpose of this study was to describe drug-related problems (DRPs) detected by pharmacy residents as well as pharmaceutical interventions in a transplant clinic.
*Methods: An observational, prospective, cross sectional study was conducted at the transplant clinic of a multi-organ transplant program. A total of 77 patients with a SOT were seen at the clinic from March to June 2019. Pharmacy residents did the following activities : medication reconciliation, detected DRPs, proposed interventions, did necessary follow-ups, and counseled patients.
*Results: A total of 104 DRPs were identified in 57 patients. At least one DRP was detected in 74% of patients seen by pharmacy residents (95% CI 0.64-0.84). The most frequent type of DRPs were untreated indication (26%), non conformity to guidelines or contraindication (16%) and drug without indication (12%). A total of 97 interventions were made in 55 patients. 71.4% of patients needed at least one pharmaceutical intervention (95% CI 0.61-0.82). The prevalence of DRPs and pharmaceutical interventions was higher in patients within their first year post-transplant. In general, both the patients and the transplant multidisciplinary team appreciated the presence of the pharmacy resident at the clinic.
*Conclusions: A high prevalence of DRPs were documented in SOT patients. The addition of a transplant pharmacist at the outpatient clinic could be beneficial to patients and the multidisciplinary transplant team.
To cite this abstract in AMA style:
Leveille-Dugas P, Bernard C, Loiselle L, Zhang Y, Coursol C, Mousseau K, Sheehan N, Cantarovich M. Implementation of a Pharmacist in an Adult Transplant Outpatient Clinic (Kidney, Liver, Pancreas): A Pilot Study – Implant [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/implementation-of-a-pharmacist-in-an-adult-transplant-outpatient-clinic-kidney-liver-pancreas-a-pilot-study-implant/. Accessed October 9, 2024.« Back to 2020 American Transplant Congress